FDA Inspection
Qilu Pharmaceutical (Hainan) Co. Ltd.Qilu Pharmaceutical (Hainan) Co. Ltd. – FDA Inspection, Aug 22, 2025
Record Details
This FDA Inspection record concerns Qilu Pharmaceutical (Hainan) Co. Ltd., with an inspection on August 22, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 767c8add-29d3-4bb2-aa95-0b733a0ece90
Inspection Facts
- Inspection number
- 1281926
- FDA center
- Human Drugs
Other FDA inspections of Qilu Pharmaceutical (Hainan) Co. Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qilu Pharmaceutical (Hainan) Co. Ltd.
- FDA Inspection 1209088 - 2023-05-19
- FDA Inspection 1111054 - 2019-11-06
- FDA Inspection 1036684 - 2017-11-17
- FDA Inspection 984197 - 2016-08-02
- FDA Inspection 880306 - 2014-05-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.